The Indian pharma industry has been acclaimed for its rapid growth in the decades and is expected to reach the US $ 100 billion by 2025. The industry clearly owes its success to its bold, ambitious approach, history of innovation and ability to constantly adapt to the global market.

However, with the country having the highest disease burden, the government has set a clear path for the future of the pharmaceutical industry and with the sector witnessing a market growth of 12.8%.

Government Initiative: Ayushman Bharat

The part of Pharmaceutical policy – "Modicare" is India's National Health Protection Scheme (NHPS) proposed in Union Budget 2018. The new scheme is touted as the world's largest government-funded health care program with participation from both the Center and state levels. 

The recommendation of Niti Aayog of PPP model policy will give a boost to the new national health protection scheme which, the private sector will support regarding infrastructure and workforce, and the government will help in proving space and funding. 

It is partly for measures such as these that India has taken huge strides regarding its reputation. According to the CPhI Worldwide Annual Industry Report 2018, with a Pharma Reputation Index of more than 40 countries, India saw an increase of 10.92% rise regarding reputation. 

Modicare "is India's National Health Protection Scheme (NHPS) proposed in Union Budget 2018. The new scheme is touted as the world's largest government-funded health care program with participation from both the Center and state levels. 

The recommendation of Niti Aayog of PPP model policy will give the boost to the new national health protection scheme which, the private sector will support regarding infrastructure and workforce, and the government will help in proving space and funding. It is partly for measures such as these that India has taken huge strides regarding its reputation.

According to the CPhI Worldwide Annual Industry Report 2018, with a Pharma Reputation Index of more than 40 countries, India saw an increase of 10.92% rise regarding reputation. This is extremely impressive given the quality and compliance issues it had faced previously.

Modicare and Hurdles

It is evident that a lot of certain hurdles need to be overcome for the gap between the planned vision and current realities to be narrowed. Modicare or NHPS intends to offer 100 million low-income families an annual cover of Rs 5 lakh each would make the most significant public health scheme.

Besides, it also aims to upgrade the existing 150,000 sub-centers all across India to improved health and wellness centers (HWCs) providing a broader range of diagnostics, and outpatient care. 

With health being a state subject, states already have their health plans running whose aims are different they cater to their entire population rather than the economically disadvantaged, aiming at a lesser amount of health cover. Of course, upgrading the sub-centers lacking in necessary infrastructure or equipment is a mammoth task.